Feature
Smart Medical Innovations to Increase Efficiency
At CES 2025, ITRI exhibited its smart medical technologies, including the High-Privacy AI Digital Caregiver, the Intelligent Medical Assistant Solution (iMAS), the AI-powered MedBobi with multilingual voice recognition and report generation, the cost-effective cybersecurity solution Janus, and the magnetic microbeads manufacturing platform iKNOBeads. These innovations aim to benefit patients, doctors, and caregivers with smarter, safer, and more efficient medical services.
High-Privacy AI Digital Caregiver
The High-Privacy AI Digital Caregiver, co-developed by ITRI and Streamteck, is an advanced remote monitoring system that utilizes thermal imaging and millimeter wave radar technologies to detect patients’ vital signs and activities with hospital-level accuracy while maintaining privacy. The system tracks bed exits, falls, and prolonged inactivity, and promptly alerts caregivers via a mobile app when abnormalities are detected.
The system detects respiration, heart rate, body temperature, blood oxygen levels, blood pressure, and falls to support patient care.
With its compact design, it is perfect for use in clinics, wards, nursing homes, and homes, offering a cost-effective telemedicine solution. This reduces the need for frequent in-person visits and checks, alleviating the workload on health workers and helping to address workforce shortages.
Intelligent Medical Assistant Solution (iMAS)
The Intelligent Medical Assistant Solution (iMAS) integrates multiple lightweight and portable medical devices to offer a comprehensive telemedicine service for patients with limited access to healthcare. Its intelligent medical imaging technology aids in diagnostic interpretation, enabling physicians to provide remote diagnoses and monitor patient conditions in real time to prevent treatment delays.
iMAS provides patients in remote areas with convenient access to medical care.
When visiting rural areas, physicians can easily carry the portable iMAS to deliver swift diagnosis and care. iMAS serves as a “homespital” solution that seamlessly combines home care and hospital services. It has been licensed to 36 vendors including collaboration with Thailand’s largest telecom company.
MedBobi
MedBobi is a smart medical assistant system that uses multimodal generative AI and retrieval-augmented generation (RAG) technology to rapidly create medical reports from voice input and other data. It can understand up to 96 languages such as English, Mandarin, Taiwanese, Japanese, Spanish, French, and Thai, and can convert speech into text, reducing medical staff’s administrative work time by 75%.
MedBobi integrates voice input, pathological images, and patient records to deliver AI-powered, personalized medical recommendations.
The system integrates voice input, pathological images, and patient records to provide AI-powered personalized medical recommendations. Additionally, MedBobi features a professional dementia database, allowing users to better understand the disease through text-based Q&A and obtain personalized care plans.
Janus
Janus is an AI-powered cybersecurity solution that proactively protects connected medical devices from cyber threats by monitoring M-IoT communications in real time and detecting suspicious activities. It simplifies network logs, updates firewalls dynamically, and streamlines compliance processes. This not only enhances product security but also boosts market competitiveness. Janus offers a reliable and efficient tool for robust healthcare data protection, ensuring smart cybersecurity in medical devices.
Through Janus’s dashboard, companies can adjust their security settings based on their specific needs and risk assessments.
iKNOBeads
iKNOBeads, the world’s first and only magnetic microbeads with controllable morphology, are designed to activate immune cells in the fight against diseases. Their uniform bead size ensures batch-to-batch reproducibility, while the bumpy body design maximizes cell interaction, enhancing activation efficiency and reducing the required bead quantity. The adaptability of iKNOBeads technology, through surface modification, allows for a wide range of immunotherapy applications, promising potential breakthroughs in disease treatment that could revolutionize the field and bring hope to millions.
To promote the iKNOBeads platform, ITRI announced a partnership between its upcoming spinoff InnoCell Tech and Reliance Biotech Corporation, Singapore-based Reliance Medical Technology (RMT) Group’s subsidiary, on the opening day of CES 2025. The partners will address the growing international demand for cancer and autoimmune disease treatments by commercializing the iKNOBeads platform.
ITRI announced a partnership with Reliance Biotech Corporation to commercialize the iKNOBeads platform on the opening day of CES 2025.
“This year, we are excited to announce that ITRI’s upcoming spinoff company InnoCell Tech will collaborate with Reliance Biotech Corporation to launch the iKNOBeads platform to the global market including the U.S. The partnership aims to secure a key position in the supply chain and enter the immunotherapy market,” said ITRI President Edwin Liu.
“The collaboration is a strong partnership, as ITRI excels in technological capabilities, while RMT Group has long possessed international resources and market access. This also marks the first step in tapping into the global market and will benefit more patients worldwide,” said Sean Ishihara, Chairman of RMT Group.